ATE297983T1 - Diagnose und behandlung von krankheiten mittels anti-t-zell rezeptor-vbeta-antikörper oder peptide, an denen diese antikörper spezifisch binden, und esrp1 - Google Patents
Diagnose und behandlung von krankheiten mittels anti-t-zell rezeptor-vbeta-antikörper oder peptide, an denen diese antikörper spezifisch binden, und esrp1Info
- Publication number
- ATE297983T1 ATE297983T1 AT98935160T AT98935160T ATE297983T1 AT E297983 T1 ATE297983 T1 AT E297983T1 AT 98935160 T AT98935160 T AT 98935160T AT 98935160 T AT98935160 T AT 98935160T AT E297983 T1 ATE297983 T1 AT E297983T1
- Authority
- AT
- Austria
- Prior art keywords
- antibodies
- esrp1
- peptides
- diagnosis
- disease
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/42—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins
- C07K16/4208—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig
- C07K16/4241—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig against anti-human or anti-animal Ig
- C07K16/4258—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig against anti-human or anti-animal Ig against anti-receptor Ig
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6854—Immunoglobulins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/04—Endocrine or metabolic disorders
- G01N2800/042—Disorders of carbohydrate metabolism, e.g. diabetes, glucose metabolism
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/24—Immunology or allergic disorders
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB9715281A GB2327423B (en) | 1997-07-21 | 1997-07-21 | Ligands, including antibodies, showing reactivity against endocrine cells for use in therapy and diagnosis |
GBGB9810676.8A GB9810676D0 (en) | 1998-05-18 | 1998-05-18 | Ligands including antibodies showing reactivity against endocrine cells for use in therapy and diagnosis |
PCT/GB1998/002151 WO1999005175A2 (en) | 1997-07-21 | 1998-07-20 | Diagnosis and treatment of diseases using anti-anti-t-cell receptor vbeta anti-bodies or peptides which are recognized by said antibodies, and endocrine secretion regulatory protein i (esrp1) |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE297983T1 true ATE297983T1 (de) | 2005-07-15 |
Family
ID=26311906
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT98935160T ATE297983T1 (de) | 1997-07-21 | 1998-07-20 | Diagnose und behandlung von krankheiten mittels anti-t-zell rezeptor-vbeta-antikörper oder peptide, an denen diese antikörper spezifisch binden, und esrp1 |
Country Status (21)
Country | Link |
---|---|
US (2) | US6689359B1 (de) |
EP (2) | EP1595951A1 (de) |
JP (1) | JP2002511765A (de) |
KR (2) | KR100670070B1 (de) |
CN (1) | CN1330754C (de) |
AT (1) | ATE297983T1 (de) |
AU (1) | AU758455B2 (de) |
BR (1) | BR9810118A (de) |
CA (1) | CA2296842C (de) |
CU (1) | CU23412A3 (de) |
DE (1) | DE69830588T2 (de) |
DK (1) | DK0998556T3 (de) |
EA (1) | EA003131B1 (de) |
ES (1) | ES2245034T3 (de) |
IL (3) | IL133277A0 (de) |
NZ (1) | NZ501424A (de) |
PL (1) | PL204503B1 (de) |
PT (1) | PT998556E (de) |
SI (1) | SI0998556T1 (de) |
TR (1) | TR200000181T2 (de) |
WO (1) | WO1999005175A2 (de) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001021799A1 (en) * | 1999-09-23 | 2001-03-29 | Rigel Pharmaceuticals, Inc. | Traf4 associated cell cycle proteins, compositions and methods of use |
DE10303974A1 (de) | 2003-01-31 | 2004-08-05 | Abbott Gmbh & Co. Kg | Amyloid-β(1-42)-Oligomere, Verfahren zu deren Herstellung und deren Verwendung |
AU2012244244B2 (en) * | 2005-08-11 | 2015-08-27 | Arpi Matossian-Rogers | TCR-V-beta related peptides for treatment and diagnosis of autoimmune disease |
NZ566245A (en) * | 2005-08-11 | 2012-04-27 | Matossian Rogers Arpi | Tcr-v-beta related peptides for treatment and diagnosis of autoimmune disease |
BRPI0619249A2 (pt) | 2005-11-30 | 2011-09-20 | Abbott Lab | anticorpos anti-globulÈmeros-aß, frações que se ligam a antìgeno destes, hibridomas correspondentes, ácidos nucléicos, vetores, células hospedeiras, métodos de produzir os ditos anticorpos, composições compreendendo os ditos anticorpos, usos dos ditos anticorpos e métodos de usar os ditos anticorpos |
CN101506236B (zh) | 2005-11-30 | 2012-12-12 | 雅培制药有限公司 | 抗淀粉样β蛋白的单克隆抗体及其用途 |
US8455626B2 (en) | 2006-11-30 | 2013-06-04 | Abbott Laboratories | Aβ conformer selective anti-aβ globulomer monoclonal antibodies |
EP2486928A1 (de) | 2007-02-27 | 2012-08-15 | Abbott GmbH & Co. KG | Verfahren zur Behandlung von Amyloidosen |
US8613923B2 (en) | 2007-06-12 | 2013-12-24 | Ac Immune S.A. | Monoclonal antibody |
US8048420B2 (en) | 2007-06-12 | 2011-11-01 | Ac Immune S.A. | Monoclonal antibody |
CN101883790B (zh) | 2007-10-05 | 2015-09-09 | 基因技术公司 | 抗淀粉样蛋白β抗体在眼病中的用途 |
MX360403B (es) | 2010-04-15 | 2018-10-31 | Abbvie Inc | Proteinas de union a amiloide beta. |
RU2607368C2 (ru) | 2010-07-30 | 2017-01-10 | Ац Иммуне С.А. | Безопасные и функциональные гуманизированные антитела |
JP6147665B2 (ja) | 2010-08-14 | 2017-06-14 | アッヴィ・インコーポレイテッド | アミロイドベータ結合タンパク質 |
BR112014007717B1 (pt) * | 2011-09-29 | 2021-07-20 | Cellsnap, Llc | Métodos in vitro de testar uma neurotoxina de clostridium botulinum (ntb) para a atividade e uso de uma célula neuronal derivada de célula-tronco pluripotente humana induzida (hips) |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2072356A1 (en) * | 1989-12-29 | 1991-06-30 | James L. Urban | Diagnosis and treatment of diseases |
US5216132A (en) * | 1990-01-12 | 1993-06-01 | Protein Design Labs, Inc. | Soluble t-cell antigen receptor chimeric antigens |
CA2101065A1 (en) * | 1991-01-22 | 1992-07-23 | Mark D. Howell | Vaccination and methods against diseases resulting from pathogenic responses by specific t cell populations |
US5480895A (en) * | 1991-09-27 | 1996-01-02 | New York Society For The Relief Of The Ruptured And Crippled, Maintaining The Hospital For Special Surgery | Method of producing antibodies to a restricted population of T lymphocytes, antibodies produced therefrom and methods of use thereof |
US5891623A (en) * | 1992-11-09 | 1999-04-06 | Consorzio Per Le Biotecnologie | Diagnosis and treatment of AIDS onset |
US5595721A (en) * | 1993-09-16 | 1997-01-21 | Coulter Pharmaceutical, Inc. | Radioimmunotherapy of lymphoma using anti-CD20 |
US5589328A (en) * | 1994-08-04 | 1996-12-31 | Mahant; Vijay K. | Chemiluminescence assays based on indoxyl substrates, thioindoxyl substrates and other substrates |
-
1998
- 1998-07-20 KR KR1020057007380A patent/KR100670070B1/ko not_active IP Right Cessation
- 1998-07-20 KR KR1020007000632A patent/KR100567277B1/ko not_active IP Right Cessation
- 1998-07-20 US US09/463,158 patent/US6689359B1/en not_active Expired - Fee Related
- 1998-07-20 DE DE69830588T patent/DE69830588T2/de not_active Expired - Lifetime
- 1998-07-20 EP EP05076378A patent/EP1595951A1/de not_active Withdrawn
- 1998-07-20 SI SI9830782T patent/SI0998556T1/xx unknown
- 1998-07-20 EP EP98935160A patent/EP0998556B1/de not_active Expired - Lifetime
- 1998-07-20 JP JP50949099A patent/JP2002511765A/ja not_active Ceased
- 1998-07-20 ES ES98935160T patent/ES2245034T3/es not_active Expired - Lifetime
- 1998-07-20 TR TR2000/00181T patent/TR200000181T2/xx unknown
- 1998-07-20 IL IL13327798A patent/IL133277A0/xx active IP Right Grant
- 1998-07-20 EA EA200000146A patent/EA003131B1/ru not_active IP Right Cessation
- 1998-07-20 CA CA2296842A patent/CA2296842C/en not_active Expired - Fee Related
- 1998-07-20 NZ NZ501424A patent/NZ501424A/en not_active IP Right Cessation
- 1998-07-20 BR BR9810118-8A patent/BR9810118A/pt not_active Application Discontinuation
- 1998-07-20 AT AT98935160T patent/ATE297983T1/de active
- 1998-07-20 PT PT98935160T patent/PT998556E/pt unknown
- 1998-07-20 WO PCT/GB1998/002151 patent/WO1999005175A2/en active IP Right Grant
- 1998-07-20 PL PL338449A patent/PL204503B1/pl not_active IP Right Cessation
- 1998-07-20 DK DK98935160T patent/DK0998556T3/da active
- 1998-07-20 AU AU84517/98A patent/AU758455B2/en not_active Ceased
- 1998-07-20 CN CNB988073803A patent/CN1330754C/zh not_active Expired - Fee Related
-
1999
- 1999-12-02 IL IL133277A patent/IL133277A/en not_active IP Right Cessation
-
2000
- 2000-01-18 CU CU20000009A patent/CU23412A3/es not_active IP Right Cessation
-
2003
- 2003-10-01 US US10/674,433 patent/US20050100541A1/en not_active Abandoned
-
2006
- 2006-05-31 IL IL176076A patent/IL176076A/en not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL176076A0 (en) | Ligands,including antibodies showing, reactivity against endocrine cells | |
DE69922261D1 (de) | Monoklonale antikörper, antigene sowie diagnose und therapie von bösartigen krankheiten | |
Lukas et al. | Inhibition of C1-mediated immune hemolysis by monomeric and dimeric peptides from the second constant domain of human immunoglobulin G. | |
MX9705610A (es) | Anticuerpos monoclonales especificos para diferentes epitopos de la gp39 humana y metodos para su uso en diagnostico y terapia. | |
DE59705683D1 (de) | IMMUNOLOGISCHES NACHWEISVERFAHREN VON ANTIKÖRPERN, DIE GEGEN GEWEBE-TRANSGLUTAMINASE (tTG) GERICHTET SIND, VERWENDUNG VON tTG ZUR DIAGNOSE UND THERAPIEKONTROLLE SOWIE ORALES PHARMAZEUTISCHES MITTEL ENTHALTEND tTG | |
CA2266325A1 (en) | A family of genes encoding apoptosis-related peptides, peptides encoded thereby and methods of use thereof | |
JP2010519180A5 (de) | ||
ATE244299T1 (de) | Test und behandlung von demyelinierenden krankheiten wie multiple sklerosis | |
RU2012120706A (ru) | Диагностические и терапевтические способы | |
JP2005531286A5 (de) | ||
ATE421531T1 (de) | Apoptose-bezogene verbindungen und deren verwendung | |
DE69638024D1 (de) | Melanoma antigene p15 und deren anwendung in diagnostischen und therapeutischen verfahren | |
WO2003072598A3 (en) | Hsp70-derived peptides an uses thereof in the diagnosis and treatment of autoimmune diseases | |
ATE215830T1 (de) | Verfahren zur detektion und behandlung von individuen mit abnormal hla-a2/tyrosinase- peptidantigenen exprimierenden zellen | |
DK0948536T3 (da) | G-protein-koblet receptor med et forstörret extracellulært domæne | |
DK0764273T3 (da) | Alfa B crystallin til anvendelse i diagnose og terapi af autoimmune sygdomme, især multipel sklerose | |
ATE191502T1 (de) | Corticotropinauslösefaktor-bindendes protein | |
Levo et al. | Diagnosis and classification of arnyloidosis by an immuno-histological method | |
Pivnik et al. | Alteration of intraerythrocyte proteolytic degradation of hemoglobin during Hodgkin's disease | |
Ito et al. | Immunohistochemical study of utrophin and dystrophin at the motor end-plate in myasthenia gravis | |
Adam et al. | Rheumatoid arthritis and collagen antibodies | |
Wallukat et al. | Peptides of the AT 1 receptor and their uses | |
FR2795414B1 (fr) | Polypeptide icbp90 et ses fragments et polynucleotides codant lesdits polypeptides et applications au diagnostic et au traitement du cancer | |
Watkins | Characterization of skeletal muscle antibodies in patients with Autoimmune rippling muscles and Myasthenia Gravis, by Thomas C. Watkins. | |
AU9134198A (en) | T-cell antigens, and their use in diagnosis and treatment of T-cell mediated conditions I |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |
Ref document number: 0998556 Country of ref document: EP |